This article is more than 5 years old. Information may no longer be current.
Immunotherapy expert joins Rush University Medical Center
Click Here to Manage Email Alerts
Timothy M. Kuzel, MD, has been appointed professor of internal medicine and division chief of hematology, oncology and cell therapy at Rush University Medical Center.
Kuzel, recognized for his work related to the development of immunotherapy treatments for cancer, succeeds Philip Bonomi, MD, who stepped down as division chief but remains on the faculty.
“Dr. Kuzel is ideally suited to sustain and accelerate Rush’s leadership in deepening the understanding of how cancer develops and can be defeated,” Jochen Reiser, MD, PhD, chair of internal medicine at Rush University Medical Center, said in a press release. “His more than 20 years of developing innovative therapies — especially those that harness the immune system — align perfectly with Rush’s philosophy of assembling multidisciplinary teams to craft individualized treatments for each patient.”
Kuzel previously served as director of Northwestern University’s Driskill Immunotherapy Research Program. He oversaw the genitourinary and cutaneous oncology programs at the Robert H. Lurie Comprehensive Cancer Center, and he also served as professor of medicine and dermatology at Northwestern University Feinberg School of Medicine.
“It is a pleasure and honor to join such a well-respected and established hematology and oncology program in Chicago,” Kuzel said in the release. “This program has served the Chicago and Midwestern community bringing compassionate and high-quality care to a broad range of patients. I look forward to working with Dr. Bonomi on a smooth transition and the opportunity to help the members of the division to achieve even more prominence in their fields of excellence.”